Skip to main content
. 2018 Sep 26;74(8):1282–1288. doi: 10.1093/gerona/gly224

Figure 3.

Figure 3.

Hazard ratio of frailty index (FI) upon time-to-death when comparing mean FI of patients on metformin plus insulin versus the mean FI of patients on metformin plus sulfonylurea. Three analytic strategies were undertaken to control for confounding: (a) unadjusted for any confounding variables, (b) direct covariate adjustment for Step 3 variables (except for antidiabetic medication regimen) reduced to the first five principal components, and (c) the same direct adjustment using first five principal components on a propensity score weighted cohort.